STERIS Return on Tangible Equity 2012-2025 | STE
Current and historical return on tangible equity values for STERIS (STE) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
| STERIS Return On Tangible Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Tangible Equity | Return on Tangible Equity |
| 2025-12-31 | $0.71B | $1.24B | 72.65% |
| 2025-09-30 | $0.69B | $1.06B | 88.48% |
| 2025-06-30 | $0.65B | $0.93B | 103.03% |
| 2025-03-31 | $0.62B | $0.67B | 133.19% |
| 2024-12-31 | $0.47B | $0.46B | 143.34% |
| 2024-09-30 | $0.44B | $0.46B | 1000.00% |
| 2024-06-30 | $0.40B | $0.27B | -134.45% |
| 2024-03-31 | $0.38B | $0.13B | -74.75% |
| 2023-12-31 | $0.57B | $-0.67B | -112.17% |
| 2023-09-30 | $0.55B | $-0.91B | -100.59% |
| 2023-06-30 | $0.12B | $-0.57B | -21.36% |
| 2023-03-31 | $0.11B | $0.13B | -15.46% |
| 2022-12-31 | $-0.03B | $-0.84B | 2.74% |
| 2022-09-30 | $-0.01B | $-0.97B | 0.69% |
| 2022-06-30 | $0.38B | $-1.10B | -29.04% |
| 2022-03-31 | $0.24B | $-1.19B | -16.69% |
| 2021-12-31 | $0.28B | $-1.37B | -23.78% |
| 2021-09-30 | $0.25B | $-1.54B | -29.27% |
| 2021-06-30 | $0.29B | $-1.75B | -96.87% |
| 2021-03-31 | $0.40B | $-0.03B | 140.26% |
| 2020-12-31 | $0.43B | $-0.09B | 104.26% |
| 2020-09-30 | $0.42B | $0.69B | 78.70% |
| 2020-06-30 | $0.41B | $0.57B | 91.63% |
| 2020-03-31 | $0.41B | $0.50B | 106.53% |
| 2019-12-31 | $0.39B | $0.40B | 121.58% |
| 2019-09-30 | $0.34B | $0.34B | 126.55% |
| 2019-06-30 | $0.32B | $0.30B | 152.15% |
| 2019-03-31 | $0.30B | $0.26B | 199.34% |
| 2018-12-31 | $0.27B | $0.17B | 264.37% |
| 2018-09-30 | $0.32B | $0.12B | 495.69% |
| 2018-06-30 | $0.30B | $0.07B | 1361.80% |
| 2018-03-31 | $0.29B | $0.06B | -1337.93% |
| 2017-12-31 | $0.24B | $0.02B | -335.17% |
| 2017-09-30 | $0.14B | $-0.05B | -119.92% |
| 2017-06-30 | $0.12B | $-0.11B | -79.47% |
| 2017-03-31 | $0.11B | $-0.15B | -62.29% |
| 2016-12-31 | $0.14B | $-0.17B | -70.94% |
| 2016-09-30 | $0.17B | $-0.17B | -70.49% |
| 2016-06-30 | $0.14B | $-0.21B | -71.71% |
| 2016-03-31 | $0.11B | $-0.24B | -121.98% |
| 2015-12-31 | $0.09B | $-0.32B | 417.78% |
| 2015-09-30 | $0.11B | $0.02B | 71.79% |
| 2015-06-30 | $0.13B | $0.18B | 66.50% |
| 2015-03-31 | $0.14B | $0.21B | 67.25% |
| 2014-12-31 | $0.13B | $0.22B | 60.18% |
| 2014-09-30 | $0.12B | $0.20B | 50.72% |
| 2014-06-30 | $0.12B | $0.18B | 45.94% |
| 2014-03-31 | $0.13B | $0.29B | 44.56% |
| 2013-12-31 | $0.13B | $0.31B | 47.31% |
| 2013-09-30 | $0.15B | $0.29B | 59.39% |
| 2013-06-30 | $0.16B | $0.27B | 63.01% |
| 2013-03-31 | $0.16B | $0.24B | 50.80% |
| 2012-12-31 | $0.16B | $0.21B | 43.37% |
| 2012-09-30 | $0.15B | $0.30B | 34.20% |
| 2012-06-30 | $0.14B | $0.50B | 29.42% |
| 2012-03-31 | $0.14B | $0.49B | 29.69% |
| 2011-12-31 | $0.13B | $0.45B | 28.84% |
| 2011-09-30 | $0.12B | $0.44B | 26.42% |
| 2011-06-30 | $0.13B | $0.47B | 28.05% |
| 2011-03-31 | $0.05B | $0.47B | 12.11% |
| 2010-12-31 | $0.04B | $0.43B | 10.14% |
| 2010-09-30 | $0.06B | $0.42B | 14.72% |
| 2010-06-30 | $0.06B | $0.39B | 13.25% |
| 2010-03-31 | $0.13B | $0.45B | 28.52% |
| 2009-12-31 | $0.13B | $0.42B | 28.65% |
| 2009-09-30 | $0.12B | $0.49B | 26.21% |
| 2009-06-30 | $0.11B | $0.45B | 26.49% |
| 2009-03-31 | $0.11B | $0.41B | 27.69% |
| 2008-12-31 | $0.11B | $0.40B | 27.97% |
| 2008-09-30 | $0.10B | $0.42B | 25.90% |
| 2008-06-30 | $0.09B | $0.38B | 22.49% |
| 2008-03-31 | $0.08B | $0.37B | 18.51% |
| 2007-12-31 | $0.08B | $0.42B | 18.65% |
| 2007-09-30 | $0.08B | $0.43B | 18.51% |
| 2007-06-30 | $0.08B | $0.44B | 19.06% |
| 2007-03-31 | $0.08B | $0.44B | 20.35% |
| 2006-12-31 | $0.06B | $0.41B | 15.24% |
| 2006-09-30 | $0.07B | $0.38B | 17.02% |
| 2006-06-30 | $0.07B | $0.37B | 16.81% |
| 2006-03-31 | $0.07B | $0.40B | 17.23% |
| 2005-12-31 | $0.09B | $0.41B | 21.45% |
| 2005-09-30 | $0.08B | $0.40B | 20.02% |
| 2005-06-30 | $0.09B | $0.38B | 20.54% |
| 2005-03-31 | $0.09B | $0.41B | 20.06% |
| 2004-12-31 | $0.09B | $0.45B | 20.69% |
| 2004-09-30 | $0.09B | $0.42B | 21.82% |
| 2004-06-30 | $0.10B | $0.44B | 22.58% |
| 2004-03-31 | $0.09B | $0.45B | 23.28% |
| 2003-12-31 | $0.09B | $0.41B | 23.61% |
| 2003-09-30 | $0.08B | $0.38B | 23.03% |
| 2003-06-30 | $0.08B | $0.36B | 23.45% |
| 2003-03-31 | $0.08B | $0.38B | 23.60% |
| 2002-12-31 | $0.07B | $0.35B | 22.58% |
| 2002-09-30 | $0.06B | $0.32B | 21.66% |
| 2002-06-30 | $0.06B | $0.30B | 19.64% |
| 2002-03-31 | $0.05B | $0.30B | 17.24% |
| 2001-12-31 | $0.01B | $0.27B | 3.97% |
| 2001-09-30 | $0.01B | $0.26B | 2.45% |
| 2001-06-30 | $0.00B | $0.24B | 1.69% |
| 2001-03-31 | $0.00B | $0.24B | 0.43% |
| 2000-12-31 | $-0.01B | $0.24B | -2.66% |
| 2000-09-30 | $-0.01B | $0.23B | -2.21% |
| 2000-06-30 | $0.00B | $0.22B | 0.87% |
| 2000-03-31 | $0.01B | $0.22B | 4.38% |
| 1999-12-31 | $0.06B | $0.25B | 27.24% |
| 1999-09-30 | $0.08B | $0.23B | 34.01% |
| 1999-06-30 | $0.08B | $0.22B | 38.55% |
| 1999-03-31 | $0.09B | $0.23B | 41.67% |
| 1998-12-31 | $0.08B | $0.20B | 39.33% |
| 1998-09-30 | $0.07B | $0.18B | 39.12% |
| 1998-06-30 | $0.07B | $0.20B | 38.90% |
| 1998-03-31 | $0.07B | $0.19B | 38.58% |
| 1997-12-31 | $0.06B | $0.16B | 36.75% |
| 1997-09-30 | $0.06B | $0.15B | 34.29% |
| 1997-06-30 | $0.05B | $0.19B | 30.59% |
| 1997-03-31 | $-0.03B | $0.18B | -17.54% |
| 1996-12-31 | $-0.04B | $0.16B | -30.00% |
| 1996-09-30 | $-0.05B | $0.19B | -46.39% |
| 1996-06-30 | $-0.06B | $0.17B | -72.27% |
| 1996-03-31 | $0.02B | $0.05B | 31.68% |
| 1995-12-31 | $0.02B | $0.05B | 31.25% |
| 1995-09-30 | $0.01B | $0.05B | 31.28% |
| 1995-06-30 | $0.01B | $0.05B | 21.56% |
| 1995-03-31 | $0.01B | $0.04B | 23.08% |
| 1994-12-31 | $0.01B | $0.04B | 21.33% |
| 1994-09-30 | $0.01B | $0.04B | 19.86% |
| 1994-06-30 | $0.01B | $0.04B | 18.05% |
| 1994-03-31 | $0.01B | $0.04B | 19.05% |
| 1993-12-31 | $0.01B | $0.03B | 17.09% |
| 1993-09-30 | $0.01B | $0.03B | 19.42% |
| 1993-06-30 | $0.00B | $0.03B | 17.58% |
| 1993-03-31 | $0.00B | $0.03B | 10.13% |
| 1992-12-31 | $0.00B | $0.02B | 13.79% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $24.357B | $5.460B |
| STERIS plc, develops, manufactures and markets infection prevention, decontamination, microbial reduction, and surgical and gastrointestinal support products and services. On Nov 2, 2015, STERIS completed the acquisition of Synergy Health plc following which it was re-registered under the name ' STERIS plc. Currently, STERIS serves healthcare, pharmaceutical, research, industrial and governmental customers across the globe. The majority of STERIS' revenues is derived from the healthcare and pharmaceutical industries. STERIS provides its products and services in more than 60 countries. The company's key areas of strategic focus include developing its customer base in Europe, the Middle East and the Asia Pacific region. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $189.665B | 22.07 |
| Intuitive Surgical (ISRG) | United States | $172.536B | 66.55 |
| IDEXX Laboratories (IDXX) | United States | $50.254B | 48.15 |
| Edwards Lifesciences (EW) | United States | $44.027B | 29.64 |
| Alcon (ALC) | Switzerland | $39.174B | 26.40 |
| IQVIA Holdings (IQV) | United States | $28.430B | 15.36 |
| Mettler-Toledo (MTD) | United States | $27.662B | 31.81 |
| DexCom (DXCM) | United States | $26.948B | 33.50 |
| Waters (WAT) | United States | $19.256B | 24.63 |
| Coloplast (CLPBY) | Denmark | $17.511B | 26.79 |
| Hologic (HOLX) | United States | $16.752B | 17.53 |
| SONOVA HOLDING (SONVY) | Switzerland | $15.334B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $14.168B | 11.75 |
| Penumbra (PEN) | United States | $13.288B | 93.47 |
| Globus Medical (GMED) | United States | $11.790B | 24.74 |
| SARTORIUS (SSSGY) | Germany | $7.976B | 46.32 |
| Masimo (MASI) | United States | $6.991B | 22.40 |
| Glaukos (GKOS) | United States | $6.287B | 0.00 |
| Sysmex ADR (SSMXY) | Japan | $5.363B | 17.75 |
| Teleflex (TFX) | United States | $4.585B | 7.31 |
| TransMedics (TMDX) | United States | $4.437B | 52.57 |
| LivaNova (LIVN) | United Kingdom | $3.593B | 19.41 |
| Integer Holdings (ITGR) | United States | $3.011B | 14.13 |
| Veracyte (VCYT) | United States | $2.828B | 32.22 |
| Elekta AB (EKTAY) | Sweden | $2.266B | 21.19 |
| Alphatec Holdings (ATEC) | United States | $1.985B | 0.00 |
| Nihon Kohden (NHNKY) | Japan | $1.975B | 21.79 |
| UFP Technologies (UFPT) | United States | $1.896B | 25.03 |
| Artivion (AORT) | United States | $1.734B | 58.10 |
| Pulse Biosciences (PLSE) | United States | $1.559B | 0.00 |
| PROCEPT BioRobotics (PRCT) | United States | $1.553B | 0.00 |
| AxoGen (AXGN) | United States | $1.533B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.285B | 0.00 |
| IRadimed (IRMD) | United States | $1.270B | 57.03 |
| OPKO Health (OPK) | United States | $0.944B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $0.882B | 4.78 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.692B | 13.80 |
| SiBone (SIBN) | United States | $0.665B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.614B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.612B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.591B | 34.35 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.530B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.516B | 0.00 |
| NeuroPace (NPCE) | United States | $0.501B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.500B | 13.03 |
| AngioDynamics (ANGO) | United States | $0.452B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.424B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.385B | 0.00 |
| RxSight (RXST) | United States | $0.331B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.329B | 54.76 |
| Semler Scientific (SMLR) | United States | $0.311B | 2.32 |
| Sight Sciences (SGHT) | United States | $0.283B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.281B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.235B | 0.00 |
| 908 Devices (MASS) | United States | $0.235B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.183B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.175B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.173B | 0.00 |
| Inogen (INGN) | United States | $0.156B | 0.00 |
| Nano-X Imaging (NNOX) | Israel | $0.149B | 0.00 |
| LENSAR (LNSR) | United States | $0.146B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.146B | 0.00 |
| Zomedica (ZOMDF) | United States | $0.132B | 0.00 |
| CVRx (CVRX) | United States | $0.130B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.119B | 0.00 |
| Hyperfine (HYPR) | United States | $0.108B | 0.00 |
| Neuronetics (STIM) | United States | $0.097B | 0.00 |
| Solana (HSDT) | United States | $0.091B | 0.00 |
| DarioHealth (DRIO) | United States | $0.079B | 0.00 |
| QT Imaging Holdings (QTIH) | United States | $0.078B | 0.00 |
| InspireMD (NSPR) | United States | $0.074B | 0.00 |
| Positron (POSC) | United States | $0.067B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.067B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.063B | 0.00 |
| Accuray (ARAY) | United States | $0.062B | 0.00 |
| Spectral AI (MDAI) | United States | $0.048B | 0.00 |
| Precision Optics (POCI) | United States | $0.037B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.036B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.026B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.021B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.020B | 0.00 | |
| Envoy Medical (COCH) | United States | $0.017B | 0.00 |
| Check-Cap (MBAI) | Israel | $0.013B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.012B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.011B | 0.00 |
| NexGel (NXGL) | United States | $0.011B | 0.00 |
| PAVmed (PAVM) | United States | $0.010B | 0.00 |
| Tenon Medical (TNON) | United States | $0.008B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.006B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.004B | 0.00 |
| Nuwellis (NUWE) | United States | $0.004B | 0.00 |
| ENvue Medical (FEED) | United States | $0.003B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.000B | 0.00 |